SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001594864-17-000046
Filing Date
2017-11-01
Accepted
2017-11-01 16:44:20
Documents
74
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q juno-09302017x10q.htm 10-Q 1412163
2 EXHIBIT 4.4 ex-44x0930201710q.htm EX-4.4 22905
3 EXHIBIT 31.1 ex-311x0930201710q.htm EX-31.1 12907
4 EXHIBIT 31.2 ex-312x0930201710q.htm EX-31.2 12377
5 EXHIBIT 32.1 ex-321x0930201710q.htm EX-32.1 7405
6 EXHIBIT 32.2 ex-322x0930201710q.htm EX-32.2 7407
  Complete submission text file 0001594864-17-000046.txt   6475602

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT juno-20170930.xml EX-101.INS 1385987
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT juno-20170930.xsd EX-101.SCH 46757
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT juno-20170930_cal.xml EX-101.CAL 84616
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT juno-20170930_def.xml EX-101.DEF 226589
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT juno-20170930_lab.xml EX-101.LAB 577845
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT juno-20170930_pre.xml EX-101.PRE 373139
Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Filer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36781 | Film No.: 171169517
SIC: 2836 Biological Products, (No Diagnostic Substances)